Literature DB >> 19841260

An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris.

Magali Saint-Geniez1, Tomoki Kurihara, Eiichi Sekiyama, Angel E Maldonado, Patricia A D'Amore.   

Abstract

Clinical and experimental observations indicate a role for VEGF secreted by the retinal pigment epithelium (RPE) in the maintenance of the choriocapillaris (CC). VEGF in mice is produced as three isoforms, VEGF120, VEGF164, and VEGF188, that differ in their ability to bind heparan sulfate proteoglycan. RPE normally produces the more soluble isoforms, VEGF120 and VEGF164, but virtually no VEGF188, reflecting the fact that molecules secreted by the RPE must diffuse across Bruch's membrane (BrM) to reach the choriocapillaris. To determine the role of RPE-derived soluble VEGF on the choriocapillaris survival, we used mice that produce only VEGF188. VEGF188/188 mice exhibited normal choriocapillaris development. However, beginning at 7 months of age, we observed a progressive degeneration characterized by choriocapillaris atrophy, RPE and BrM abnormalities, culminating in areas of RPE loss and dramatic choroidal remodeling. Increased photoreceptor apoptosis in aged VEGF188/188 mice led to a decline in visual acuity as detected by electroretinogram (ERG). These changes are reminiscent of geographic atrophy (GA) and point to a role for RPE-derived VEGF in the maintenance of the choriocapillaris.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19841260      PMCID: PMC2774033          DOI: 10.1073/pnas.0905010106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  VEGF receptor signalling - in control of vascular function.

Authors:  Anna-Karin Olsson; Anna Dimberg; Johan Kreuger; Lena Claesson-Welsh
Journal:  Nat Rev Mol Cell Biol       Date:  2006-05       Impact factor: 94.444

Review 2.  Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential.

Authors:  Ian Zachary
Journal:  Neurosignals       Date:  2005

3.  Vascular endothelial growth factor localization in the adult.

Authors:  Arindel S R Maharaj; Magali Saint-Geniez; Angel E Maldonado; Patricia A D'Amore
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

4.  VEGF189 stimulates endothelial cells proliferation and migration in vitro and up-regulates the expression of Flk-1/KDR mRNA.

Authors:  Marie-Astrid Hervé; Hélène Buteau-Lozano; Samia Mourah; Fabien Calvo; Martine Perrot-Applanat
Journal:  Exp Cell Res       Date:  2005-09-10       Impact factor: 3.905

5.  Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function.

Authors:  Alexander G Marneros; Jie Fan; Yoshihito Yokoyama; Hans Peter Gerber; Napoleone Ferrara; Rosalie K Crouch; Bjorn R Olsen
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

6.  VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature.

Authors:  Tomomi Kamba; Betty Y Y Tam; Hiroya Hashizume; Amy Haskell; Barbara Sennino; Michael R Mancuso; Scott M Norberg; Shaun M O'Brien; Rachel B Davis; Lori C Gowen; Keith D Anderson; Gavin Thurston; Shuji Joho; Matthew L Springer; Calvin J Kuo; Donald M McDonald
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-09-19       Impact factor: 4.733

7.  Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation.

Authors:  H G Blaauwgeers; G M Holtkamp; H Rutten; A N Witmer; P Koolwijk; T A Partanen; K Alitalo; M E Kroon; A Kijlstra; V W van Hinsbergh; R O Schlingemann
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

8.  Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele.

Authors:  P Carmeliet; V Ferreira; G Breier; S Pollefeyt; L Kieckens; M Gertsenstein; M Fahrig; A Vandenhoeck; K Harpal; C Eberhardt; C Declercq; J Pawling; L Moons; D Collen; W Risau; A Nagy
Journal:  Nature       Date:  1996-04-04       Impact factor: 49.962

9.  The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences.

Authors:  D T Shima; M Kuroki; U Deutsch; Y S Ng; A P Adamis; P A D'Amore
Journal:  J Biol Chem       Date:  1996-02-16       Impact factor: 5.157

Review 10.  The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease.

Authors:  David I R Holmes; Ian Zachary
Journal:  Genome Biol       Date:  2005-02-01       Impact factor: 13.583

View more
  200 in total

1.  Evolution of the VEGF-regulated vascular network from a neural guidance system.

Authors:  Sreenivasan Ponnambalam; Mario Alberghina
Journal:  Mol Neurobiol       Date:  2011-01-28       Impact factor: 5.590

Review 2.  Therapeutic targets in age-related macular disease.

Authors:  Alan C Bird
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

Review 3.  Emerging therapeutic approaches in the management of retinal angiogenesis and edema.

Authors:  An Truong; Tien Y Wong; Levon M Khachigian
Journal:  J Mol Med (Berl)       Date:  2010-12-18       Impact factor: 4.599

4.  Choroidal imaging in inherited retinal disease using the technique of enhanced depth imaging optical coherence tomography.

Authors:  Jonathan Yeoh; Waheeda Rahman; Fred Chen; Claire Hooper; Praveen Patel; Adnan Tufail; Andrew R Webster; Anthony T Moore; Lyndon Dacruz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-07-17       Impact factor: 3.117

5.  Re: Cho et al. "Long-term visual outcome and prognostic factors of intravitreal anti-vascular endothelial growth factor treatment for retinal angiomatous proliferation".

Authors:  Akin Cakir; Eyup Duzgun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01-21       Impact factor: 3.117

6.  Comparison of intravitreal aflibercept and ranibizumab injections on subfoveal and peripapillary choroidal thickness in eyes with neovascular age-related macular degeneration.

Authors:  Cheolmin Yun; Jaeryung Oh; Jaemoon Ahn; Soon-Young Hwang; Boram Lee; Seong-Woo Kim; Kuhl Huh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01-19       Impact factor: 3.117

7.  VEGF 165 b in the developing vasculatures of the fetal human eye.

Authors:  Takayuki Baba; D Scott McLeod; Malia M Edwards; Carol Merges; Tanusree Sen; Debasish Sinha; Gerard A Lutty
Journal:  Dev Dyn       Date:  2012-01-31       Impact factor: 3.780

Review 8.  Clinical pharmacology of intravitreal anti-VEGF drugs.

Authors:  Stefano Fogli; Marzia Del Re; Eleonora Rofi; Chiara Posarelli; Michele Figus; Romano Danesi
Journal:  Eye (Lond)       Date:  2018-02-05       Impact factor: 3.775

9.  Targeted deletion of Vegfa in adult mice induces vision loss.

Authors:  Toshihide Kurihara; Peter D Westenskow; Stephen Bravo; Edith Aguilar; Martin Friedlander
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

Review 10.  Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.

Authors:  S Scott Whitmore; Elliott H Sohn; Kathleen R Chirco; Arlene V Drack; Edwin M Stone; Budd A Tucker; Robert F Mullins
Journal:  Prog Retin Eye Res       Date:  2014-12-05       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.